PTSD Screening vs Diagnosis: How Assessment Works
Author: Ukrainian Psychological Hub · Published: October 9, 2026 · Editorial Policy
A positive PTSD screening result means that a person may need further evaluation. A PTSD diagnosis is a clinical conclusion reached after evaluating traumatic exposure, the pattern and duration of symptoms, distress or functional impairment, and alternative explanations. A brief questionnaire can identify possible posttraumatic stress disorder (PTSD); it cannot establish every requirement for the disorder. The 2023 VA/DoD guideline recommends a brief screen when screening is indicated and a validated, structured clinician-administered interview for diagnostic confirmation.
This guide explains the difference between screening, symptom measurement, provisional classification, and a clinical diagnosis. It covers the tools most often encountered in American practice, how clinicians use DSM-5-TR and ICD-11, what happens during an assessment, how false-positive and false-negative results arise, and what to do next. It also explains why the same symptom score can mean different things across people and settings.
For a broader explanation and related clinical context, see Posttraumatic Stress Disorder (PTSD): Symptoms, Diagnosis, and Treatment.
PTSD Screening and Diagnosis: The Essential Difference
Screening asks a limited question: Is there enough evidence of possible PTSD to justify a more complete evaluation? A diagnostic assessment asks a wider question: Do the person's history, symptoms, timing, impairment, and clinical context meet the criteria for a particular disorder? The difference determines what can responsibly be inferred from the result. The VA National Center for PTSD distinguishes brief self-screens from structured interviews and explains that a more comprehensive assessment is needed to diagnose PTSD.
Four levels of assessment
First, identification of potentially traumatic exposure establishes what happened and how it relates to the relevant diagnostic system. Second, brief screening looks for indicators that further assessment may be useful. Third, detailed symptom measurement estimates severity and sometimes produces a provisional or probable PTSD classification. Fourth, a clinician integrates exposure, symptom clusters, duration, impairment, differential diagnosis, safety and comorbid conditions in a diagnostic evaluation. These stages can overlap within one appointment; a clinician may proceed directly to a comprehensive interview when symptoms warrant it.
A provisional classification is useful for referral, monitoring or research inclusion, but is a working assessment. A formal clinical diagnosis requires interpretation within an accepted diagnostic framework. Someone can also have distressing trauma-related symptoms worthy of treatment without meeting the full criteria for PTSD. The NICE PTSD guideline NG116 explicitly addresses people with clinically important symptoms who do not necessarily have a diagnosis established by clinical interview.
What a positive or negative screen means
A positive screen raises concern and prompts follow-up; it is not a declaration that PTSD is present. A negative result lowers concern to a degree determined by the instrument's sensitivity, the setting and the person's presentation; it cannot exclude the disorder with certainty. A score can be misleading if the person has difficulty disclosing trauma, understands an item differently, completes a measure in a language for which it was not validated, or experiences overlapping symptoms from another condition. When clinical concern persists, assessment can proceed regardless of the screening score.
How Clinicians Diagnose PTSD
1. Establish the type of traumatic exposure
Under DSM-5-TR, PTSD requires qualifying exposure to actual or threatened death, serious injury or sexual violence through specified pathways: direct experience, in-person witnessing, learning of certain violent or accidental events affecting close family or friends, or repeated or extreme occupational exposure to aversive details. Nonoccupational exposure solely through electronic media does not ordinarily qualify. An event may be profoundly painful or destabilizing without meeting DSM Criterion A; its mental health consequences still deserve assessment and care. The VA's DSM-5-TR clinical summary describes the exposure criterion and additional diagnostic requirements.
A clinician may ask which event is currently connected to symptoms, whether there were several events, whether the person remains exposed to danger, and whether discussing the event is safe. A useful assessment can establish the diagnostic facts without demanding a graphic recounting of every detail. When histories are complicated, repeated interviews may be preferable to a hurried account.
2. Evaluate the complete symptom pattern
For adults under DSM-5-TR, assessment covers intrusive re-experiencing, avoidance, negative changes in cognition and mood, and altered arousal or reactivity. Symptoms are examined in relation to the traumatic event and assessed for onset, frequency, intensity and impact. The person need not have every listed symptom, but must meet the required cluster pattern. Nightmares, heightened vigilance, sleep loss, irritability or emotional numbness in isolation are insufficient for diagnosis. The National Center for PTSD reports that the DSM-5-TR adult PTSD criteria remained unchanged from DSM-5.
Clinicians distinguish unwanted memories or trauma-linked nightmares from ordinary remembering; protective caution from persistent hypervigilance; clinically relevant avoidance from situational preference; and trauma-linked changes from symptoms better explained by another disorder. Dissociation may require additional careful questions about depersonalization and derealization. The dissociative subtype is a PTSD specifier and does not automatically establish a separate dissociative disorder.
3. Check duration, distress and functioning
In DSM-5-TR, the PTSD symptom disturbance must persist longer than one month, and cause clinically significant distress or impairment. Assessment considers work, school, relationships, sleep, daily activities and safety, including effects that are not visible to other people. Symptoms developing soon after exposure may instead fall within an acute stress response or, when the specific criteria are met during the first month, acute stress disorder. Reassessment over time may change the diagnosis as the clinical picture evolves.
The clinician also evaluates whether substances, medication effects, neurological or other medical conditions account for the symptoms. The diagnostic conclusion rests on the combined pattern, rather than a high total score alone.
4. Assess other conditions, immediate needs and personal context
A thorough evaluation can include depression, anxiety disorders, obsessive-compulsive symptoms, adjustment disorder, substance use, sleep disorders, traumatic brain injury, chronic pain, dissociative disorders, and psychotic or manic symptoms where relevant. Trauma-linked intrusions may resemble OCD-related unwanted thoughts, but their phenomenology, triggers and associated responses can differ; the Hub's existing OCD vs PTSD comparison discusses this specific differential. Co-occurring disorders can also be present simultaneously and may change the care plan.
Clinicians should assess current safety, self-harm or suicide risk when indicated, ongoing violence, access to basic needs, social supports, medication use, physical health and barriers to care. NICE NG116 calls for a comprehensive physical, psychological and social assessment with risk assessment. A person who needs urgent safety intervention should receive it irrespective of whether PTSD criteria are established.
The Main PTSD Assessment Tools and What They Can Establish
PC-PTSD-5: brief primary-care screening
The Primary Care PTSD Screen for DSM-5 (PC-PTSD-5) is a short screening instrument intended for settings such as primary care. It starts with a trauma-exposure question and, when exposure is endorsed, asks five yes/no questions about experiences during the preceding month. The resulting score runs from 0 to 5. According to the VA measure description, a positive result calls for further evaluation, preferably a structured PTSD interview.
In a 2021 diagnostic accuracy study in 396 US veterans, the trade-off between identifying cases and avoiding false alarms differed by cut point. A cut point of 3 increased sensitivity compared with 4, while 4 offered higher specificity in that study. Those numbers reflect the study population and reference assessment, not a universal rule for every clinic, age group or demographic group. The 2023 VA/DoD guideline suggests the PC-PTSD-5 for screening rather than as a stand-alone diagnostic tool.
PCL-5: detailed self-reported symptom severity
The PTSD Checklist for DSM-5 (PCL-5) is a 20-item self-report scale covering the DSM-5 symptom domains, usually referring to the past month. It can support screening, provisional classification and repeated measurement during care. It does not, by its total score alone, verify every exposure, duration, impairment or differential-diagnostic requirement. The VA PCL-5 guide identifies a structured clinical interview such as the CAPS-5 as the reference approach for diagnostic confirmation.
A systematic review of 64 PCL-5 studies found generally supportive reliability and validity evidence, while reporting substantial variability in optimal cutoff scores. Scores around 31–33 commonly appear in the literature, but no single threshold fits every population or purpose. A 2025 reanalysis of a German clinical sample showed that selecting a cutoff for clinical screening, estimating prevalence or defining research samples can produce different preferred values. A score above any threshold is evidence for follow-up, not proof of PTSD.
Because the PCL-5 measures severity, clinicians may use it repeatedly to follow change across treatment, alongside functioning and patient priorities. A lower score may signal improvement; it need not mean all problems have resolved. A high score may reflect overlapping depression, anxiety or sleep-related symptoms and requires clinical interpretation. The more detailed scoring questions belong to the planned dedicated PCL-5 article in this cluster.
CAPS-5: a structured clinician-administered diagnostic interview
The Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) is a structured interview often used as a reference standard in research and specialized practice. The VA CAPS-5 overview describes a 30-item interview examining each of the 20 DSM symptom items, frequency and intensity, onset and duration, impairment, overall severity, response validity and dissociative features. It requires trained clinical administration and a qualifying index event. The format makes different components of the diagnosis explicit and reproducible.
CAPS-5 may take substantially longer than a screen and often requires careful pacing. A trained professional uses standardized prompts and clinical judgment to decide whether endorsed experiences meet the symptom criteria. A structured interview improves consistency but does not turn mental health diagnosis into an infallible mechanical procedure.
Other clinician interviews and trauma-exposure measures
The 2023 VA/DoD guideline synopsis suggests a validated, structured clinician-administered interview, such as CAPS-5 or the PTSD Symptom Scale–Interview for DSM-5 (PSSI-5), to confirm diagnosis. Instruments such as the Life Events Checklist (LEC-5) can help systematically document potentially qualifying exposures; a list of life events alone does not diagnose PTSD. More general diagnostic interviews, including the SCID, can help investigate competing and co-occurring disorders. Instrument choice follows the diagnostic question and the clinician's training.
ICD-11 ITQ and ITI: PTSD and complex PTSD
The International Trauma Questionnaire (ITQ) is a self-report measure designed around ICD-11 PTSD and complex PTSD. It measures ICD-11 core PTSD symptoms, disturbances in self-organization, and related impairment. The VA ITQ overview describes its provisional diagnostic and dimensional uses. The International Trauma Interview (ITI) is a clinician-administered interview that systematically evaluates ICD-11 PTSD and complex PTSD, including duration, impairment and clinical validity; the VA ITI overview documents its training requirements.
A 2026 comparison of ITQ and ITI results in 108 treatment-seeking Danish veterans found that the self-report instrument generally elicited more symptom endorsement than the clinician interview. Agreement differed by diagnostic category, reinforcing the importance of interview-based clinical evaluation. The finding is informative but derived from one specific veteran sample and should not be generalized automatically to all populations.
DSM-5-TR and ICD-11: Why Diagnostic Systems Can Differ
The DSM-5-TR is widely used for US clinical diagnosis. The World Health Organization's ICD-11 is an international diagnostic classification with its own PTSD formulation. The WHO clinical descriptions and diagnostic requirements provide the relevant professional framework. The classifications overlap substantially, but they organize symptoms differently; a questionnaire aligned with one system is not an interchangeable test for the other.
DSM-5-TR evaluates PTSD through four symptom domains, requires the more detailed Criterion A exposure definition, and includes a dissociative specifier. ICD-11 emphasizes three core features: re-experiencing in the present, avoidance, and a persistent sense of current threat, together with functional impairment. ICD-11 also recognizes complex PTSD as a separate diagnosis involving those PTSD features plus persistent disturbances in affect regulation, negative self-concept and relationships. DSM-5-TR does not have a separate complex PTSD diagnosis.
Differences in criteria can change who receives a PTSD classification under a given system, even when the person's distress is unchanged. A clinical-sample validation study by Hyland and colleagues found different diagnostic rates using ICD-11-aligned and DSM-5-aligned measures. That study illustrates the effect of classification rules; it should not be interpreted as establishing that one classification is universally more accurate. Clinicians should identify which system they are applying and document it consistently.
False Positives, False Negatives, and the Meaning of a Cutoff
Why a positive test does not equal a diagnosis
Sensitivity refers to how often an assessment correctly flags people who have the target condition under the chosen reference standard; specificity refers to how often it correctly identifies those who do not. Screening deliberately balances the risk of missed cases against unnecessary referrals. Positive predictive value also depends on how common the disorder is in the group being tested. Therefore the same score and cutoff can yield very different probabilities in a specialty trauma clinic and in a general-population survey.
For example, a scale with reasonably strong sensitivity can still generate many positive screens among people who do not meet full diagnostic criteria when PTSD prevalence is low. Conversely, a high cutoff reduces some false alarms but may miss people who need care. A 2026 systematic review of PTSD instrument studies identifies important gaps in validation across populations and measures. Clinical interpretation requires the measure's intended population, language and reference standard, not simply its marketing description as a PTSD test.
Why people can screen negative and still need care
Some people underreport because they fear stigma, feel unsafe, have difficulty naming symptoms, or cannot readily connect them to an event. Others encounter a measure with poor fit for their language, age, disability or trauma history. Symptoms may fluctuate, and dissociative experiences can make questioning harder. A low screen does not negate observed impairment or a person's report that something is wrong. A clinician can arrange another interview, use a better-matched measure, investigate another disorder, or repeat assessment when clinically appropriate.
Online quizzes, AI assessments and self-diagnosis
An online form can help someone organize symptoms and decide to seek an appointment when the questions come from a validated instrument used as intended. Anonymous websites often omit the instrument's version, cutoffs, validation population or clinician follow-up. Automated or AI-generated interpretations can summarize answers but have not thereby established diagnostic validity. Clinicians use interviews, contextual information and safety assessment that are not captured by a generic symptom score. Never delay necessary care because a website says a person has low PTSD risk.
What Happens During a PTSD Evaluation?
Before the appointment
A first visit may begin with referral information, a short symptom screen, medication and medical history, and questions about the person's main concerns. It is reasonable to ask about the assessor's experience with PTSD, confidentiality rules, whether questionnaires will be used, and whether a support person may attend. The VA's patient-facing assessment explanation encourages patients to ask about the provider's training and the assessment process.
During the clinical interview
The clinician usually establishes a working timeline of exposure and symptoms, checks their links, examines distress and functional changes, and asks about other mental and physical health problems. Questions about a traumatic event may be uncomfortable, so a good assessment explains why details are requested, uses a manageable pace, and makes space for breaks. Patients can say that they need more time, ask about why a question is necessary or disclose that they cannot answer it safely at that moment. Assessment can be staged while urgent needs are addressed.
A professional should also consider whether the person is currently safe and whether talking about traumatic memories could increase immediate distress. Asking about suicidal thinking, self-harm, intoxication, psychosis, or interpersonal violence when indicated is part of responsible evaluation; it does not imply that these are universal features of PTSD.
After the interview
The clinician may explain that PTSD criteria are met, that another diagnosis better describes the findings, that symptoms remain subthreshold or that more information is needed. A useful assessment concludes with a shared plan: discussion of the diagnosis and uncertainty, practical supports, follow-up, therapy options, and management of co-occurring problems. Ask for the specific symptoms and criteria supporting a diagnosis, the role of any questionnaire score, and what further evaluation would change the conclusion.
Where PTSD is diagnosed or clinically important symptoms warrant treatment, the care plan can include evidence-based trauma-focused psychotherapy. VA/DoD, NICE and the APA 2025 PTSD treatment guideline describe treatment recommendations. Assessing whether PTSD is present is a separate decision from selecting prolonged exposure, cognitive processing therapy, EMDR, other trauma-focused treatments, medication, or supportive care. Treatment suitability depends on clinical needs, safety, access and preferences.
Special Assessment Situations
The first month after a traumatic event
In the initial days or weeks after trauma, people may have intrusive memories, disturbed sleep, anxiety, numbness or increased alertness without developing PTSD. For DSM-5-TR PTSD the disturbance lasts longer than a month, while acute stress disorder has a different timing window and diagnostic pattern. Early assessment should focus on safety, distress, functioning and whether follow-up is needed. The NICE guideline advises active monitoring for subthreshold PTSD symptoms within one month of exposure and appropriate follow-up. Waiting for a duration threshold is never a reason to ignore immediate risk or clinically significant suffering.
Children and adolescents
PTSD assessment in children requires attention to developmental level, caregiver reports, behavioral changes and age-appropriate instruments. Young children may show trauma-related themes through play or changes in behavior rather than describe symptoms in adult language. DSM-5-TR includes developmentally sensitive PTSD criteria for children six years and younger. Clinicians should consider the reliability and limitations of information from both child and caregivers, the possibility of continuing exposure, and potential differences between home and school observations. NICE NG116 gives age-specific recognition and care recommendations.
Complex trauma, dissociation and repeated exposure
People with repeated exposure, broad functional difficulties or substantial dissociation may need a more extended evaluation. The assessor should distinguish PTSD with dissociative features, ICD-11 complex PTSD and separate dissociative conditions according to the framework being used. A history of childhood adversity can matter greatly, but history alone does not establish complex PTSD; assessment requires the relevant symptom and impairment pattern. The VA's complex PTSD assessment guidance outlines how the ITQ and clinician interview contribute. For context about early exposures rather than this article's diagnostic process, see Childhood Trauma and PTSD: What Is the Connection?.
Culture, language, disability and the setting
Interview questions and questionnaire cutoffs may behave differently across languages and social groups. An assessor should use an appropriately validated language version where available and qualified interpreting support when needed, rather than assuming literal translation preserves measurement accuracy. Migration, discrimination, disability, sexual violence and occupation may affect disclosure, trust, access and safety. Assessments in military services, primary care, emergency departments and specialty clinics have different time constraints and different prior probabilities of PTSD. Research from one setting must be transferred cautiously to another.
Does a PTSD Diagnosis Require a Brain Scan or Blood Test?
No laboratory test, brain scan or wearable stress reading currently replaces clinical diagnostic evaluation for PTSD. Research on neurobiology and physiological correlates contributes to scientific understanding, but group-level associations do not constitute validated stand-alone clinical diagnostic tests for an individual patient. Medical investigations may still be necessary to explain symptoms, address injury, evaluate sleep problems, or investigate co-occurring health conditions. The VA patient resource explains that a PTSD assessment primarily involves questions about thoughts, feelings and behavior rather than specialized equipment.
When to Seek an Assessment and How to Prepare
Seek professional evaluation when trauma-related experiences persist, intensify, interfere with work or relationships, disturb sleep, lead to significant avoidance, or make everyday life increasingly difficult. You may also seek care promptly in the days after an event if distress is severe. A screening result can be brought to the appointment, ideally with the questionnaire name, version, date, time frame and scoring instructions. Preparing a short chronology of symptoms, current safety concerns, medications and previous treatment can help, but detailed written trauma narratives are not required.
Questions worth asking include: Which diagnostic framework are you using? Did my exposure meet the relevant criterion? What other conditions were considered? What does my screening score actually indicate? Are additional interviews needed? How will symptoms and functioning be monitored? What options for treatment and follow-up fit my circumstances? A person who is at immediate risk of suicide, facing current violence, or unable to remain safe needs urgent local emergency or crisis services without waiting for screening or formal diagnosis.
Frequently Asked Questions
Can a PTSD questionnaire diagnose me?
A questionnaire may identify probable PTSD or provide a provisional classification. Confirming diagnosis requires the clinician to establish qualifying exposure, the full symptom pattern, timing, distress or impairment and alternative explanations. For ICD-11 PTSD or complex PTSD, the ITQ similarly informs evaluation but is not a replacement for a clinician interview.
Is the PCL-5 score of 33 a PTSD diagnosis?
No. Scores around 31–33 have often been studied as screening cutoffs, but their operating characteristics vary by population and purpose. The PCL-5 systematic review and subsequent 2025 cutoff study explain this variability. The score is a prompt to interpret symptoms and consider further evaluation.
What is the most accurate PTSD test?
For DSM-aligned adult diagnostic assessment, the CAPS-5 is a widely used structured reference-standard interview. Accuracy also depends on clinician training, thorough exposure assessment, honest and safe disclosure, and differential evaluation. There is no context-free single test that perfectly classifies every person.
Can you have PTSD with a low score or no flashbacks?
Screening can miss some cases, so ongoing symptoms merit clinical attention despite a low score. Dramatic visual flashbacks are not required: re-experiencing can take forms such as distressing unwanted memories or nightmares, provided the complete diagnostic requirements are met. Not every disturbing memory represents PTSD.
Can PTSD be diagnosed immediately after a traumatic event?
Under DSM-5-TR, PTSD requires a symptom duration longer than one month. Acute stress symptoms and acute stress disorder can be assessed earlier; urgent care and support should be provided according to need, not postponed for the PTSD duration threshold. The timing requirements in ICD-11 are framed differently and should be assessed in that system.
Who can diagnose PTSD?
Appropriately qualified and licensed health professionals diagnose within their professional scope and jurisdiction. Mental health clinicians commonly conduct in-depth assessment; primary-care professionals may initiate assessment, make diagnoses where permitted, and coordinate referrals. Ask about trauma-assessment training and the use of validated interviews.
Can I have both PTSD and another disorder?
Yes. Clinicians may diagnose co-occurring depression, anxiety, OCD, substance-use disorders or other conditions if each meets its respective criteria. Some symptoms overlap, so a detailed interview is especially valuable. The published GAD vs PTSD comparison explains one common diagnostic boundary.
Can I request a second evaluation?
Yes. A second opinion is reasonable when a diagnosis is unclear, the assessment felt incomplete, dissociation or comorbid symptoms were overlooked, or the resulting treatment plan is not fitting your needs. Bring previous results, describe discrepancies and ask which criteria remain uncertain.
Key Takeaway
PTSD screening identifies who may benefit from further assessment; clinical diagnosis determines whether the full pattern of exposure, symptoms, timing and impairment meets a particular diagnostic framework. PC-PTSD-5 is a brief screen, PCL-5 is primarily a symptom measure with provisional classification uses, CAPS-5 is a structured DSM-aligned diagnostic interview, and ITQ/ITI serve ICD-11 PTSD and complex PTSD assessment. Their results should be interpreted together with clinical history, safety, context, differential diagnoses and the person's goals. The most useful assessment ends with a clear explanation and a practical plan for care.
Related Articles
OCD vs PTSD: What Is the Difference? — overlapping intrusive experiences and diagnostic distinctions.
GAD vs PTSD: Worry, Trauma, Hyperarousal, and Avoidance — distinctions when anxiety symptoms overlap.
Childhood Trauma and PTSD: What Is the Connection? — exposure history and later posttraumatic outcomes.
Traumatic Neurosis: Historical Meaning and Its Relationship to PTSD — how diagnostic concepts have changed.
References
American Psychological Association. (2025). Clinical Practice Guideline for the Treatment of Posttraumatic Stress Disorder (PTSD) in Adults. Official guideline.
Bovin, M. J., Kimerling, R., Weathers, F. W., et al. (2021). Diagnostic accuracy and acceptability of the Primary Care PTSD Screen for DSM-5 among US veterans. JAMA Network Open, 4(2), e2036733. https://doi.org/10.1001/jamanetworkopen.2020.36733.
Cloitre, M., Shevlin, M., Brewin, C. R., et al. (2018). The International Trauma Questionnaire: Development of a self-report measure of ICD-11 PTSD and complex PTSD. Acta Psychiatrica Scandinavica, 138, 536–546. https://doi.org/10.1111/acps.12956.
Coeur, E., Giaufer, C., Robert, P., & Corveleyn, X. (2026). A systematic review of PTSD instruments: Psychometric properties and validity in DSM-5 and ICD-11 based tools. Journal of Affective Disorders, 394, 120484. https://doi.org/10.1016/j.jad.2025.120484.
Forkus, S. R., Raudales, A. M., Rafiuddin, H. S., et al. (2023). The Posttraumatic Stress Disorder Checklist for DSM-5: A systematic review of existing psychometric evidence. Clinical Psychology, 30, 110–121. https://doi.org/10.1037/cps0000111.
Hyland, P., et al. (2017). Validation of post-traumatic stress disorder and complex PTSD using the International Trauma Questionnaire. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/acps.12771.
Melkevik, O., Roberts, N., & Folke, S. (2026). Self-reported versus clinician-evaluated symptom assessment and diagnosis of ICD-11 PTSD and CPTSD: A comparison between the International Trauma Interview and the International Trauma Questionnaire. European Journal of Psychotraumatology, 17(1), 2635917. https://doi.org/10.1080/20008066.2026.2635917.
National Institute for Health and Care Excellence. (2018; reviewed 2025). Post-traumatic stress disorder (NG116): Recommendations. Official guideline.
Pettrich, A., Schellong, J., Dyer, A., et al. (2025). Beyond one-cutoff-fits-all: Determining cutoff values for the PTSD Checklist for DSM-5 (PCL-5). European Journal of Psychotraumatology. https://doi.org/10.1080/20008066.2025.2514878.
U.S. Department of Veterans Affairs, National Center for PTSD. (n.d.). Clinician-Administered PTSD Scale for DSM-5 (CAPS-5). Official assessment reference.
U.S. Department of Veterans Affairs, National Center for PTSD. (n.d.). International Trauma Interview (ITI). Official assessment reference.
U.S. Department of Veterans Affairs, National Center for PTSD. (n.d.). International Trauma Questionnaire (ITQ). Official assessment reference.
U.S. Department of Veterans Affairs, National Center for PTSD. (n.d.). Primary Care PTSD Screen for DSM-5 (PC-PTSD-5). Official screening reference.
U.S. Department of Veterans Affairs, National Center for PTSD. (n.d.). PTSD and DSM-5: Diagnostic criteria and DSM-5-TR updates. Official clinical reference.
U.S. Department of Veterans Affairs, National Center for PTSD. (n.d.). PTSD Checklist for DSM-5 (PCL-5). Official assessment reference.
U.S. Department of Veterans Affairs and U.S. Department of Defense. (2023). VA/DoD Clinical Practice Guideline for the Management of Posttraumatic Stress Disorder and Acute Stress Disorder. Official guideline.
World Health Organization. (2024). Clinical descriptions and diagnostic requirements for ICD-11 mental, behavioural and neurodevelopmental disorders. Official publication.